Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABMTOTCMKTS:ADYXOTCMKTS:AKSYOTCMKTS:EMED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00-75.0%$0.00$0.00▼$0.00$7K1.56N/A22,000 shsADYXAlliqua BioMedical$0.00$0.00▼$0.00N/A1.98N/AN/AAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/AEMEDElectromedical Technologies$0.00+100.0%$0.00$0.00▼$0.00N/AN/A69.19 million shs10.96 million shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies-75.00%-75.00%-75.00%-75.00%-83.33%ADYXAlliqua BioMedical0.00%0.00%0.00%0.00%0.00%AKSYAksys0.00%0.00%0.00%0.00%0.00%EMEDElectromedical Technologies+100.00%+100.00%+100.00%0.00%-62.96%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AADYXAlliqua BioMedicalN/AN/AN/AN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AN/AN/AN/AEMEDElectromedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMTAdvanced Biomedical Technologies 0.00N/AN/AN/AADYXAlliqua BioMedical 0.00N/AN/AN/AAKSYAksys 0.00N/AN/AN/AEMEDElectromedical Technologies 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMTAdvanced Biomedical Technologies$270K0.03N/AN/AN/A∞ADYXAlliqua BioMedicalN/AN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AN/AEMEDElectromedical TechnologiesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMTAdvanced Biomedical Technologies-$510KN/A0.00∞N/AN/AN/AN/AN/AADYXAlliqua BioMedicalN/AN/A0.00N/AN/AN/AN/AN/AN/AAKSYAksysN/AN/A0.00N/AN/AN/AN/AN/AN/AEMEDElectromedical TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AADYXAlliqua BioMedicalN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AEMEDElectromedical TechnologiesN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMTAdvanced Biomedical TechnologiesN/AADYXAlliqua BioMedicalN/AAKSYAksysN/AEMEDElectromedical Technologies0.01%Insider OwnershipCompanyInsider OwnershipABMTAdvanced Biomedical Technologies34.11%ADYXAlliqua BioMedical17.40%AKSYAksys3.80%EMEDElectromedical Technologies1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMTAdvanced Biomedical Technologies2070.91 millionN/ANot OptionableADYXAlliqua BioMedical6N/AN/ANot OptionableAKSYAksys87N/AN/ANot OptionableEMEDElectromedical Technologies7N/AN/ANot OptionableEMED, ABMT, AKSY, and ADYX HeadlinesRecent News About These CompaniesElectromed is a new Buy at B. Riley; Buyout potential citedFebruary 20, 2025 | msn.comElectromedical Technologies Unveils Groundbreaking Details About the WellnessPro Infinity and Announces Production TimelineDecember 11, 2024 | accesswire.comAElectromedical Technologies, Inc.: Electromedical Provides Update to ShareholdersAugust 8, 2024 | finanznachrichten.deElectromedical Provides Update to ShareholdersAugust 8, 2024 | accesswire.comAeMed Partners with i3screen to Launch Virtual Drug Screening Program for EmployersMay 15, 2024 | valdostadailytimes.comVMTD acquires Ypsomed's pen needle and BGM businesses, strengthening its leading position in diabetes careMarch 28, 2024 | msn.comElectromedical Technologies IncOctober 26, 2023 | thestreet.comElectromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement.March 22, 2023 | finance.yahoo.comElectromedical Technologies expects Q4 revenue to be up 79% Y/YMarch 14, 2023 | msn.comElectromedical Technologies, Inc. (EMED)January 2, 2023 | finance.yahoo.comElectromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022December 5, 2022 | finance.yahoo.comElectromedical Technologies Introduces the WellnessPro Infinity™November 1, 2022 | finance.yahoo.comEMED Electromedical Technologies, Inc.September 20, 2022 | seekingalpha.comElectromedical's Flagship WellnessPro Plus Technology on Exhibit This Week at PAINWeek 2022 in Las Vegas from Sep 6-9September 8, 2022 | finance.yahoo.comElectromedical Technologies Announces Financial and Operational Highlights for the Three and Six Months Ended June 30, 2022August 18, 2022 | finance.yahoo.comElectromedical Technologies Announces Financial and Operational Highlights for the Three Months Ended March 31, 2022May 24, 2022 | finance.yahoo.comElectromedical Technologies Announces 2021 Annual Financial ResultsApril 7, 2022 | finance.yahoo.comElectromedical Technologies Inc (EMED)January 17, 2022 | nasdaq.comElectromedical Technologies, Inc. Reports Third Quarter 2021 Financial ResultsNovember 18, 2021 | finance.yahoo.comElectromedical Technologies Receives Key Medical Device CertificationSeptember 30, 2021 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEMED, ABMT, AKSY, and ADYX Company DescriptionsAdvanced Biomedical Technologies OTCMKTS:ABMT$0.0001 0.00 (-75.00%) As of 07/7/2025 12:32 PM EasternAdvanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.Alliqua BioMedical OTCMKTS:ADYXAdynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.Aksys OTCMKTS:AKSYAksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.Electromedical Technologies OTCMKTS:EMED$0.0002 +0.00 (+100.00%) As of 07/7/2025 03:59 PM EasternElectromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. The company also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play Why Centene Stock Dropped 40% — And Whether It's a Buy Now D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
